Podcasts about Yale school

Today, on Notable Leaders' Radio, I speak with Elizabeth Haggerty,  EVP Customer Solutions, America's Division, CRH. She highlights how navigating life's and career pivots, unexpected business challenges, and a life-changing health diagnosis led her to discover untapped reserves of courage and resilience, offering real-life strategies to thrive through uncertainty and continual growth. In today's episode, we discuss: Adopt the "one foot in, one foot out" approach. When considering a new role or industry, bring core skills you already have while stretching into new territory, so you're growing without completely untethering yourself. Let your setbacks refine, not define, you. When a business is sold, or a role ends abruptly, even through being fired, treat it as a painful but powerful pivot point, not a verdict on your worth or future potential. Integrate joy and self-care into your life. Make space for passions, hobbies, and relationships outside of work. These experiences not only enhance your overall well-being but also give you energy and perspective to face professional challenges with renewed spirit. Redefine your identity beyond job titles. Reflect on how external achievements and positions have shaped your sense of self. Shift your focus from titles to your skill sets, values, and unique contributions. This empowers you to navigate transitions and derive fulfillment from multiple aspects of life. Release the need to do everything alone. Accept that asking for help is a sign of wisdom, not weakness. Rely on your team's expertise and focus on asking insightful questions. This collaborative approach strengthens outcomes and develops your leadership. Guest Bio: Elizabeth Haggerty is a high-impact executive with over a 35-year history of driving growth and profitability in the building products industry.   Starting in the HVAC industry leading global product and channel P&Ls before transitioning to the industrial material products space where she has led large P&L businesses and key customer growth strategies.   Liz has experience in green fielding businesses as well as leading turn arounds and corporate carve-outs.   All of this done through building and developing high performing teams and investing in leadership development.  She has a bachelor's and master's degree in metallurgical engineering and an MBA.  Elizabeth has been recognized by:  Glass Magazine as one of the industry's Most Influential People,  Engineered Systems Magazine as 20 Women to Watch  HVAC and by Industry Week for women in manufacturing.   She was also recognized by the Manufacturing Institute a Women in Manufacturing Step Ahead Honoree in 2021. Website/Social Links LinkedIn: https://www.linkedin.com/in/elizabeth-haggerty-81885115/  Belinda's Bio: Belinda is a sought-after Leadership Advisor, Coach, Consultant and Keynote speaker and a leading authority in guiding global executives, professionals and small business owners to become today's highly respected leaders. As the Founder of BelindaPruyne.com, Belinda works with such organizations as IBM, Booz Allen Hamilton, BBDO, The BAM Connection, Hilton, Leidos, Yale School of Medicine, Landis, and the Discovery Channel. Most recently, she redesigned two global internal advertising agencies for Cella, a leader in creative staffing and consulting. She is a founding C-suite and executive management coach for Chief, the fastest-growing executive women's network. Since 2020, Belinda has delivered more than 72 interviews with top-level executives and business leaders who share their inner journey to success; letting you know the truth of what it took to achieve their success in her Notable Leaders Radio podcast. She gained a wealth of expertise in the client services industry as Executive Vice President, Global Director of Creative Management at Grey Advertising, managing 500 people around the globe. With over 20+ years of leadership development experience, she brings industry-wide recognition to the executives and companies she works with. Whether a startup, turnaround, acquisition, or global corporation, executives and companies continue to turn to Pruyne for strategic and impactful solutions in a rapidly shifting economy and marketplace. Website: Belindapruyne.com Email Address: hello@belindapruyne.com LinkedIn: https://www.linkedin.com/in/belindapruyne  Facebook: https://www.facebook.com/NotableLeadersNetwork.BelindaPruyne/  Twitter: https://twitter.com/belindapruyne?lang=en  Instagram: https://www.instagram.com/belindapruyne/ 

In his weekly clinical update, Dr. Griffin and Vincent Racaniello talk about the health misconceptions that RFK Jr continues to perpetuate and how to combat them, first cases of highly pathogenic influenza in the California elephant seal population before Dr. Griffin deep dives into economic costs of not vaccinating against measles, the measles outbreak in South Carolinaand Utah, ICE detention centers, lack of accurate reporting may prevent the US from losing its status as a country that eliminated measles, immune amnesia from measles infection, influenza strain selection for the 2026-2027 vaccine,  recent statistics for RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, where to find PEMGARDA, how to access and pay for Paxlovid, when to use steroids for treating influenza, long COVID treatment center, where to go for answers to your long COVID questions, clinical trials for long COVID treatment including GLP-1 inhibitors and IVIG and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Kristen Panthagani, MD, PhD (Substack) You can know things! (Substack) Kmpanthagani: Kristen Panthagani, MD, PhD Instagram) Kristen Panthagani, MD, PhD kmpanthagani (Threads) Psychological inoculation improves resilience against misinformation on social media (Science) 5 Logical fallacies in the era of RFK Jr. (Substack) Tecovirimat for the Treatment of Mpox (NEJM) California records avian flu in northern elephant seals (CIDRAP) First Cases of Highly Pathogenic Avian Influenza in Northern Elephant Seals Confirmed in California (UC Davis) Wastewater for measles (WasterWater Scan) The health and economic repercussions of declining MMR coverage in the United States (medRxiv) 2025 measles resurgence carries estimated $244 million price tag (CIDRAP) US builds case to retain measles elimination status as infections mount (Reuters) Expert meeting on US measles elimination status delayed to November (Reuters) 'Nearly Every' Child With Measles Suffers This Hidden Threat (Medscape) CDC acting director Bhattacharya urges use of measles vaccine (Reuters) Measles cases and outbreaks (CDC Rubeola) Measles Dashboard (South Carolina Department of Public Health) Utah measles outbreak response (Utah Department of Health and Human Services) Utah Measles Dashboard (Utah Department of Health and Human Services) Escobar: ICE sending sick migrants to El Paso hospitals for quarantine (BorderReport) Tracking Measles Cases in the U.S. (Johns Hopkins) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts(ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Flu vaccine recommendations: Vaccines and Related Biological Products Advisory Committee March 12, 2026 Meeting Announcement (FDA) WHO updates all 3 viral strains to be included in fall flu shots (CIDRAP) Weekly surveillance report: cliff notes (CDC FluView) OPTION 2: XOFLUZA $50 Cash Pay Option (xofluza) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) US respiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Respiratory Diseases (Yale School of Public Health) RSV Detection and Antibiotic Prescribing Decisions for Pediatric Respiratory Tract Infections (JAMA Network) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Where to get pemgarda (Pemgarda) EUAfor the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) Understanding Coverage Options (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulationguidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID SARS-CoV-2Persistence and the Gut Microbiota: New Insights into Long COVID Pathogenesis (MDPI) Neither Metformin nor Ursodeoxycholic Acid Effectively Treats Postacute Sequelae of COVID-19 (Annals of Internal Medicine) Long COVID: RECOVER-TLC Clinical Trials (Foundation for the National Institute of Health) Design and rationale of RECOVER-AUTONOMIC: A randomized platform trial evaluating interventions for Long COVID postural orthostatic tachycardia syndrome (American Heart Journal) Dr. Ruth's Newsletter: COVID, Flu & Health News, 3/1/26 (Substack) Reaching out to US house representative Letters read on TWiV 1302 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

People with Parkinson's disease (PD) are at a higher risk of being hospitalized and often face even greater challenges once admitted. Of the more than 1 million people living with PD in the US, nearly one third are hospitalized each year. During a hospital stay, they are more likely to receive the wrong medication, encounter missed or delayed dosages, receive medications known to worsen PD symptoms, experience limited mobility, and face a higher risk of dysphagia (difficulty swallowing). These gaps in care can lead to avoidable complications, longer hospital stays, and worse overall health outcomes.    The Parkinson's Foundation Hospital Care Initiative, launched in 2020, aims to eliminate preventable harm and promote higher quality PD inpatient care. Through this initiative, the Foundation provides hospitals with the opportunity for education, training, expertise, and the guidance necessary to improve hospital care for people with PD.     As a component of this work, the Parkinson's Foundation Hospital Care Learning Collaborative was established to foster a peer-led group of hospitals, emergency departments, and health systems committed to improving care for people with PD. This national network of hospital and clinical leaders share best practices and lessons learned from national experts to enhance care before, during, and after hospitalization.    In this episode, we speak with Rebecca Miller, an associate professor at the Yale School of Medicine in the Department of Psychiatry, and a person living with young-onset Parkinson's. She is joined by Leslie Pelton, a senior program officer with the John A. Hartford Foundation. Together, they do a deep dive into why hospital safety is especially critical for people with Parkinson's and highlight ongoing efforts to advance safer care, including initiatives such as the Age-Friendly Health Systems and the 4Ms framework.   During the episode, Leslie mentions the 4Ms Worksheet and My Health Checklist as useful tools for preparing for a hospital visit.   Follow and rate us on your favorite podcast platform to be notified when there's a new episode! Let us know what other topics you would like us to cover by visiting parkinson.org/feedback. 

New research from Yale School of Medicine revealed how exercise can slow the growth of tumors. We spoke with Dr. Rachel Perry, the author of this study, shared key takeaways and easy ways to incorporate more movement in your day.For more information: Precancer exercise capacity and metabolism during tumor development coordinate the skeletal muscle–tumor metabolic competition | PNAS

In this episode, we welcome back James Choi, Professor of Finance at the Yale School of Management, to unpack one of the most important—and misunderstood—questions in personal finance: How much of your portfolio should be in stocks? Drawing on his new paper, Practical Finance: An Approximate Solution to Lifecycle Portfolio Choice, James walks us through the classic portfolio choice problem first solved by Robert C. Merton, later extended by Francisco Gomes and co-authors, and now made dramatically more usable through a spreadsheet-based approximation. We explore how risk aversion, wealth, labor income risk, and expected returns shape optimal asset allocation, why simple rules like "100 minus your age" aren't terrible but still costly, and how James and his co-authors managed to approximate a complex dynamic optimization model with an error of less than 0.1% in lifetime welfare.   Key Points From This Episode: (0:04) Introduction and why this episode delivers on "mathy roots." (1:10) James Choi's new paper: Making lifecycle portfolio choice solvable in a spreadsheet. (5:15) The portfolio choice problem: How much should you allocate to stocks versus risk-free assets? (6:09) The classic Merton (1969, 1971) solution and the "Merton share." (8:00) The equity premium formula: Expected excess return ÷ (risk aversion × variance). (11:20) Extending the model to risky labor income (Cocco, Gomes, and Maenhout). (14:27) Why labor income behaves bond-like—even when it's risky. (16:33) How wealth, risk aversion, and labor income characteristics affect optimal equity allocation. (20:52) Transitory vs. permanent labor income risk—and why permanent risk matters more. (23:04) Solving thousands of parameter sets to approximate optimal lifecycle allocations. (27:09) How close is the approximation? ~3–4 percentage points on average, with

The Whitney Biennial is here. That would be the Whitney Museum's big curated show which every two years brings together dozens of artists, always closely watched by critics and public as a statement about what is important now in art. Hot on its heels, next month, MoMA PS1 is staging "Greater New York." That event happens every five years, bringing together dozens more artists to take the temperature of art in New York. Taína H. Cruz, my guest today, is featured in both these shows at once. For the Whitney, she is even, in a way, the face of the show: a work by Cruz, a green-tinged close-up painting of a grinning child, called I Saw the Future and It Smiled Back, is blown up on a billboard outside the museum in the Meatpacking District. This is a lot of attention for an artist who is relatively young, born in 1998, and just getting her MFA from the famed Yale School of Painting last year. She's worked in a variety of media, but is known now for paintings, often featuring images of Black female figures with a moody, woozy, sometimes unsettled or unsettling atmosphere. Sometimes Cruz works in suggestions of African American and Caribbean folklore, or intimations of horror and fantasy. Sometimes, she's played on the images of celebrities like Halle Berry or Tyra Banks. Sometimes she reworks her own personal photos of neighbors from New York. Since Cruz is an artist that the curators of these big shows are looking to, art critic, Ben Davis, wanted to get a sense of the influences—from art and otherwise— that are shaping her approach to art, and what she makes of all the attention.

Howie and Harlan are joined by Yale School of Medicine neurologist Kevin Sheth to discuss how collaboration helps drive breakthroughs in brain health, including advances in detecting stroke and other neurological diseases earlier and more precisely. Harlan reflects on lessons from his family's recent experience navigating the healthcare system; Howie examines the expanding marketplace for GLP-1 weight-loss drugs and the challenges of ensuring safe and appropriate use. Show notes: The Family Perspective Cleveland Clinic: Percutaneous Coronary Intervention "What's the Difference Between a CCU and an ICU?" Kevin Sheth Alva Health Mayo Clinic: Stroke Video: Kevin Sheth at the Yale Innovation Summit Sandra Saldana, PhD, MBA "Buddy System"  NIH: Multiple Principal Investigators "Assessing the Decade of the Brain" "Cerebrospinal fluid and plasma biomarkers in Alzheimer disease" Kevin Sheth: "Burden of Ischemic and Hemorrhagic Stroke Across the US From 1990 to 2019"  Endovascular Thrombectomy (EVT) Ischemic vs Hemorrhagic Stroke "What is cognitive reserve?"  Cheaper Obesity Drugs "Will Novo Nordisk's slashing of obesity drug prices save patients' money? It depends"  "Novo Nordisk to halve US list price of Wegovy from 2027"  "Walgreens Virtual Healthcare Adds Weight Management Services to Support Patients on Their Weight Loss Journey"  In the Yale School of Management's MBA for Executives program, you'll get a full MBA education in 22 months while applying new skills to your organization in real time. Yale's Executive Master of Public Health offers a rigorous public health education for working professionals, with the flexibility of evening online classes alongside three on-campus trainings. Email Howie and Harlan comments or questions.

The Whitney Biennial is here. That would be the Whitney Museum's big curated show which every two years brings together dozens of artists, always closely watched by critics and public as a statement about what is important now in art. Hot on its heels, next month, MoMA PS1 is staging "Greater New York." That event happens every five years, bringing together dozens more artists to take the temperature of art in New York. Taína H. Cruz, my guest today, is featured in both these shows at once. For the Whitney, she is even, in a way, the face of the show: a work by Cruz, a green-tinged close-up painting of a grinning child, called I Saw the Future and It Smiled Back, is blown up on a billboard outside the museum in the Meatpacking District. This is a lot of attention for an artist who is relatively young, born in 1998, and just getting her MFA from the famed Yale School of Painting last year. She's worked in a variety of media, but is known now for paintings, often featuring images of Black female figures with a moody, woozy, sometimes unsettled or unsettling atmosphere. Sometimes Cruz works in suggestions of African American and Caribbean folklore, or intimations of horror and fantasy. Sometimes, she's played on the images of celebrities like Halle Berry or Tyra Banks. Sometimes she reworks her own personal photos of neighbors from New York. Since Cruz is an artist that the curators of these big shows are looking to, art critic, Ben Davis, wanted to get a sense of the influences—from art and otherwise— that are shaping her approach to art, and what she makes of all the attention.

Howie and Harlan are joined by Yale School of Medicine neurologist Kevin Sheth to discuss how collaboration helps drive breakthroughs in brain health, including advances in detecting stroke and other neurological diseases earlier and more precisely. Harlan reflects on lessons from his family's recent experience navigating the healthcare system; Howie examines the expanding marketplace for GLP-1 weight-loss drugs and the challenges of ensuring safe and appropriate use. Show notes: The Family Perspective Cleveland Clinic: Percutaneous Coronary Intervention "What's the Difference Between a CCU and an ICU?" Kevin Sheth Alva Health Mayo Clinic: Stroke Video: Kevin Sheth at the Yale Innovation Summit Sandra Saldana, PhD, MBA "Buddy System"  NIH: Multiple Principal Investigators "Assessing the Decade of the Brain" "Cerebrospinal fluid and plasma biomarkers in Alzheimer disease" Kevin Sheth: "Burden of Ischemic and Hemorrhagic Stroke Across the US From 1990 to 2019"  Endovascular Thrombectomy (EVT) Ischemic vs Hemorrhagic Stroke "What is cognitive reserve?"  Cheaper Obesity Drugs "Will Novo Nordisk's slashing of obesity drug prices save patients' money? It depends"  "Novo Nordisk to halve US list price of Wegovy from 2027"  "Walgreens Virtual Healthcare Adds Weight Management Services to Support Patients on Their Weight Loss Journey"  In the Yale School of Management's MBA for Executives program, you'll get a full MBA education in 22 months while applying new skills to your organization in real time. Yale's Executive Master of Public Health offers a rigorous public health education for working professionals, with the flexibility of evening online classes alongside three on-campus trainings. Email Howie and Harlan comments or questions.

In this episode of Onc Now, Michael Cecchini, Associate Professor of Medicine at Yale School of Medicine, New Haven, Connecticut, USA, discusses his journey into gastrointestinal oncology and the evolution of care for patients with colorectal and rectal cancers. From the complexities of multidisciplinary coordination to the promise of early-phase clinical trials, Cecchini reflects on how molecular profiling and next-generation systemic therapies are reshaping treatment paradigms.  Timestamps:   00:00 – Introduction   01:13 – Path to gastrointestinal oncology  03:00 – Multidisciplinary care challenges  07:20 – Early phase trial advances  11:26 – Evolving systemic therapies  14:58 – Impact of molecular profiling  20:20 – Translating trials to practice  23:38 – Advice for clinician investigators  28:21 – Future therapeutic advances  31:50 – Three wishes for gastrointestinal care 

In today's episode, we spoke with Anne Chiang, MD, PhD, to discuss the rapidly evolving treatment landscape in small cell lung cancer (SCLC) and what this new era of innovation means for patients. Dr Chiang is an associate professor of medicine in the Section of Medical Oncology at Yale School of Medicine and associate cancer center director for clinical initiatives at Yale Cancer Center in New Haven, Connecticut.In our exclusive interview, Chiang reflected on how the field has shifted since the introduction of chemoimmunotherapy in 2018, highlighting improvements in median overall survival and the emergence of long-term responders in extensive-stage disease. Chiang also explored the growing understanding of disease heterogeneity, and the evolution of biomarker-informed strategies like under evaluation in the phase 2 S2409 PRISM trial (NCT06769126).Additionally, Chiang examined the clinical effect of DLL3-targeted therapies, including the recently approved bispecific antibody tarlatamab-dlle (Imdelltra), and how surface-targeting strategies are expanding options beyond traditional chemotherapy. Beyond efficacy, Chiang underscored the importance of individualized decision-making by assessing patient fitness beyond ECOG performance status, navigating treatment urgency in rapidly progressive disease, and balancing durability with toxicity when counseling patients on therapy.

Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.In this special Mind Moments episode, Lauren Sansing, MD, MS, FAHA, FANA, Professor of Neurology at Yale School of Medicine, joins the podcast to provide a clinical breakdown of the 2026 International Stroke Conference and its implications for real-world stroke care. Sansing reflects on how this year's meeting built on prior advances, highlighting expanded global collaboration, greater patient engagement, and a record number of clinical trials presented. The discussion explores which late-breaking studies may influence practice in the coming year, including data on secondary stroke prevention, adjunctive thrombolysis strategies, and evolving patient selection for thrombectomy in extended windows and large core infarcts. Sansing also reviews renewed momentum in neuroprotection research, key updates from the newly released acute ischemic stroke guidelines, emerging pediatric stroke data, and how the conference continues to shape the roadmap for 2027 and beyond.Looking for more Stroke discussion? Check out the NeurologyLive® Stroke clinical focus page.Episode Breakdown: 1:00 – Biggest moments and structural evolution of ISC 2026 3:15 – Presented practice-changing trial data impacting stroke care 7:05 – Thrombectomy strategy and extended window patient selection 10:40 – Renewed momentum in neuroprotection research 15:20 – Neurology News Network  17:40 – Key updates from the new acute ischemic stroke guidelines 25:00 – A brief look-ahead to ISC 2027 The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here: PTC Withdraws Ataluren Submission as Treatment for Nonsense Mutation Duchenne Muscular Dystrophy Microbiome-Targeted Agent PLL001 Passes Safety Check in Phase 1/2 Trial of ALS Rimegepant Displays Safety and Efficacy in Study of Adolescents With Migraine Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

Howie and Harlan are joined by Yale economist Janet Currie to discuss how early-life investments in health, education, and environmental protection shape children's lifelong well-being and economic opportunity. Harlan highlights a new Medicare payment model that would reward measurable improvements in chronic disease outcomes; Howie reflects on the spread of medical misinformation and a new effort to push back. Show notes: The ACCESS Payment Model CMS: ACCESS (Advancing Chronic Care with Effective, Scalable Solutions) Model "ACCESS: What this new payment model means for physicians and patients" "FDA Launches TEMPO: A First-of-Its-Kind Digital Health Pilot to Expand Access to Chronic Disease Technologies" Janet Currie "Welcoming Janet Currie: A Pioneer in the Economics of Children and Families Joins Yale" Janet Currie: "Collective Bargaining in the Public Sector: The Effect of Legal Structure on Dispute Costs and Wages" Janet Currie: "Child health as human capital" Janet Currie: "Killing Me Softly: The Fetal Origins Hypothesis" "Medicaid and Children's Health: 5 Issues to Watch Amid Recent Federal Changes" Janet Currie: "Medicaid: What Does It Do, and Can We Do It Better?" Janet Currie: "Does Head Start Make a Difference?" Janet Currie: "Longer Term Effects of Head Start" Janet Currie: "Lead and Juvenile Delinquency: New Evidence from Linked Birth, School, and Juvenile Detention Records" Head Start Impact Study (HSIS) Series Janet Currie: "Saving Babies: The Efficacy and Cost of Recent Changes in the Medicaid Eligibility of Pregnant Women" Janet Currie: "Doctor Decision Making and Patient Outcomes" Janet Currie's American Economic Association Presidential Address: "Investing in Children to Address the Child Mental Health Crisis" "Addressing Common Misconceptions About the Child Mental Health Crisis" Janet Currie: "To What Extent are Trends in Teen Mental Health Driven by Changes in Reporting?" Janet Currie: "Rules versus Discretion: Treatment of Mental Illness in US Adolescents"  Misinformation Mayo Clinic: Amyotrophic lateral sclerosis (ALS): Symptoms and causes "Inside RFK Jr.'s push against the flu vaccine that he links to his voice condition" Health & Veritas Episode 197: Peter Hotez: Mapping the Anti-Science Machine "It's time for a new era of advocacy for physicians" "Childhood Vaccination Rates Have Dropped Again, C.D.C. Data Shows" "Take It From a Scientist. Facts Matter, and They Don't Care How You Feel." "A small study on Covid vaccine safety sparks an online tempest" Health & Veritas Episode 192: Akiko Iwasaki: What Have We Learned About Long COVID? In the Yale School of Management's MBA for Executives program, you'll get a full MBA education in 22 months while applying new skills to your organization in real time. Yale's Executive Master of Public Health offers a rigorous public health education for working professionals, with the flexibility of evening online classes alongside three on-campus trainings. Email Howie and Harlan comments or questions.

AI and new tech in crises: When is technology a force for good, and when are we piling on the problems in humanitarian response? In this episode, experts unpack why technology is never neutral, the fallback on "techno-utopian" solutions, and the risk of "techno-colonialism" and why it matters.   Guests:    Mirca Madianou, professor in the School of Media, Communications and Cultural Studies at Goldsmiths, University of London, and author of "Technocolonialism: When Technology for Good is Harmful".   Nathaniel Raymond, executive director of the Humanitarian Research Lab at the Yale School of Public Health.   Rana F. Sweis, journalist and founder and managing director of WishBox Media.   Got a question or feedback? Email podcast@thenewhumanitarian.org or post on social media using the hashtag #RethinkingHumanitarianism.

Howie and Harlan are joined by Yale economist Janet Currie to discuss how early-life investments in health, education, and environmental protection shape children's lifelong well-being and economic opportunity. Harlan highlights a new Medicare payment model that would reward measurable improvements in chronic disease outcomes; Howie reflects on the spread of medical misinformation and a new effort to push back. Show notes: The ACCESS Payment Model CMS: ACCESS (Advancing Chronic Care with Effective, Scalable Solutions) Model "ACCESS: What this new payment model means for physicians and patients" "FDA Launches TEMPO: A First-of-Its-Kind Digital Health Pilot to Expand Access to Chronic Disease Technologies" Janet Currie "Welcoming Janet Currie: A Pioneer in the Economics of Children and Families Joins Yale" Janet Currie: "Collective Bargaining in the Public Sector: The Effect of Legal Structure on Dispute Costs and Wages" Janet Currie: "Child health as human capital" Janet Currie: "Killing Me Softly: The Fetal Origins Hypothesis" "Medicaid and Children's Health: 5 Issues to Watch Amid Recent Federal Changes" Janet Currie: "Medicaid: What Does It Do, and Can We Do It Better?" Janet Currie: "Does Head Start Make a Difference?" Janet Currie: "Longer Term Effects of Head Start" Janet Currie: "Lead and Juvenile Delinquency: New Evidence from Linked Birth, School, and Juvenile Detention Records" Head Start Impact Study (HSIS) Series Janet Currie: "Saving Babies: The Efficacy and Cost of Recent Changes in the Medicaid Eligibility of Pregnant Women" Janet Currie: "Doctor Decision Making and Patient Outcomes" Janet Currie's American Economic Association Presidential Address: "Investing in Children to Address the Child Mental Health Crisis" "Addressing Common Misconceptions About the Child Mental Health Crisis" Janet Currie: "To What Extent are Trends in Teen Mental Health Driven by Changes in Reporting?" Janet Currie: "Rules versus Discretion: Treatment of Mental Illness in US Adolescents"  Misinformation Mayo Clinic: Amyotrophic lateral sclerosis (ALS): Symptoms and causes "Inside RFK Jr.'s push against the flu vaccine that he links to his voice condition" Health & Veritas Episode 197: Peter Hotez: Mapping the Anti-Science Machine "It's time for a new era of advocacy for physicians" "Childhood Vaccination Rates Have Dropped Again, C.D.C. Data Shows" "Take It From a Scientist. Facts Matter, and They Don't Care How You Feel." "A small study on Covid vaccine safety sparks an online tempest" Health & Veritas Episode 192: Akiko Iwasaki: What Have We Learned About Long COVID? In the Yale School of Management's MBA for Executives program, you'll get a full MBA education in 22 months while applying new skills to your organization in real time. Yale's Executive Master of Public Health offers a rigorous public health education for working professionals, with the flexibility of evening online classes alongside three on-campus trainings. Email Howie and Harlan comments or questions.

This week, we are so excited to share the first of our Career Development Series episodes, developed in partnership with The American Society of Hematology , The ASH Trainee Council, and Hematopoiesis! For years, our listeners have reached out to our show asking for guidance to help navigate their careers. We are so excited to be partnering with an amazing organization like ASH to help make this happen!This time, we welcome two amazing guests, Dr. Hetty Carraway, Director of the Leukemia Program and the Vice Chair of Strategy and Enterprise Development at the Taussig Cancer Institute at The Cleveland Clinic, and Dr. Alfred Lee, Chief of Classical Hematology at Yale School of Medicine, for our inaugural episode where we discuss the importance of mentorship and ask them all the questions most of us have always wondered but are too afraid to ask our mentors. A MUST listen for all trainees!** This episode is created in partnership with The American Society of Hematology (hematology.org), The ASH Trainee Council (https://www.hematology.org/education/trainees/fellows/trainee-council), and Hematopoeisis (https://www.hematology.org/education/trainees/fellows/hematopoiesis) ** Want to review the show notes for this episode and others? Check out our website. Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!Twitter: @TheFellowOnCallInstagram: @TheFellowOnCallListen in on: Apple Podcast, Spotify, and Youtube

Despite major advances in our understanding of the biology of mental health disorders,  there's no blood test or brain scan that will confirm if you have depression, anxiety, PTSD, or any other psychiatric illness.  And yet, the American Psychiatric Association recently announced that it will be including biomarkers for mental conditions in the next edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM), which guides diagnosis and treatment of mental illness. So how close are we to pinpointing the biological markers of mental illness, and what does that mean for diagnosis? It's complicated.  Host Flora Lichtman untangles some of this science with psychiatry researcher John Krystal. Guest: Dr. John Krystal is a professor of psychiatry, neuroscience, and psychology at the Yale School of Medicine. Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.

Welcome to OncLive On Air®! I'm your host today, Courtney Flaherty.OncLive On Air is a podcast from OncLive®, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive covers every angle of oncology practice, from new technology to treatment advances to important regulatory decisions.In today's episode, Philippos Costa, MD, and Hari Deshpande, MD sat down to discuss and answer frequently asked questions about chondrosarcoma in honor of International Chondrosarcoma Awareness Day. This included common pitfalls in the diagnostic process for this rare, heterogenous bone malignancy; the central role of surgery as the primary treatment for localized chondrosarcoma; and the potential application of IDH1-targeted therapy, DR5 agonists, and other emerging targeted therapies in this sarcoma subtype.Dr Deshpande is an associate professor of medicine, clinical research team leader in sarcoma, and the director of Medical Oncology Inpatient Consult Service in the Section of Medical Oncology at Yale School of Medicine. Dr Costa is an oncologist and assistant professor of medicine (Medical Oncology and Hematology) at Yale School of Medicine._____That's all we have for today! Thank you for listening to this episode of OncLive On Air. Check back throughout the week for exclusive interviews with leading experts in the oncology field.For more updates in oncology, be sure to visit www.OncLive.com and sign up for our e-newsletters.OncLive is also on social media. On X and BlueSky, follow us at @OncLive. On Facebook, like us at OncLive, and follow our OncLive page on LinkedIn.If you liked today's episode of OncLive On Air, please consider subscribing to our podcast on Apple Podcasts, Spotify, and many of your other favorite podcast platforms,* so you get a notification every time a new episode is posted. While you are there, please take a moment to rate us!Thanks again for listening to OncLive On Air.*OncLive On Air is available on: Apple Podcasts, Spotify, CastBox, Podcast Addict, Podchaser, RadioPublic, and TuneIn.This content is a production of OncLive. The current episode was filmed in advance of Chondrosarcoma Day, observed on February 6, 2026

Howie and Harlan are joined by Evangelos Oikonomou, a cardiologist and data scientist at the Yale School of Medicine, to discuss how AI can extract overlooked signs of heart disease from routine ECGs, imaging studies, and electronic health records—and how to deploy those tools responsibly at scale. Harlan explains whether a widely covered study suggesting that coffee may lower the risk of dementia should change your daily brew; Howie grapples with the ethical questions surrounding a proposed hepatitis B vaccine trial in Guinea-Bissau. Show notes: Coffee and Dementia "Coffee and Tea Intake, Dementia Risk, and Cognitive Function" "Coffee linked to slower brain ageing in study of 130,000 people" "2 to 3 Cups of Coffee a Day May Reduce Dementia Risk. But Not if It's Decaf." Evangelos Oikonomou "What Is Opportunistic Screening in Healthcare?" Evangelos Oikonomou: "Artificial intelligence in medical imaging: A radiomic guide to precision phenotyping of cardiovascular disease" Evangelos Oikonomou: "Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data" Evangelos Oikonomou: "Artificial intelligence-guided detection of under-recognised cardiomyopathies on point-of-care cardiac ultrasonography: a multicentre study" "Fellow Focus in Four: Evangelos Oikonomou, MD, DPhil, Cardiovascular Medicine" Health & Veritas Episode 80: Josh Geballe: Turning Yale Innovation into Startups Evangelos Oikonomou: "TARGET-AI: A Foundational Approach for the Targeted Deployment of Artificial Intelligence Electrocardiography in the Electronic Health Record" "Using AI to Guide AI" "Are A.I. Tools Making Doctors Worse at Their Jobs?" "The Robot Doctor Will See You Now" Health & Veritas Episode 207: Robert Wachter: AI Is Already Remaking Healthcare "A large language model for complex cardiology care" Vaccine Trial Ethics WHO: Statement on the planned hepatitis B birth dose vaccine trial in Guinea-Bissau "Planned US-funded baby vaccine trial in Guinea-Bissau blasted by WHO" "Guinea-Bissau suspends US-funded vaccine trial as African scientists question its motives" "Guinea-Bissau Installs Military Ruler After Claims of a 'Fabricated' Coup" In the Yale School of Management's MBA for Executives program, you'll get a full MBA education in 22 months while applying new skills to your organization in real time. Yale's Executive Master of Public Health offers a rigorous public health education for working professionals, with the flexibility of evening online classes alongside three on-campus trainings. Email Howie and Harlan comments or questions.

Today, on Notable Leaders' Radio, I speak with  Melissa Muir, acclaimed jewelry artist and teacher. She highlights how embracing life's unexpected pivot points opens new paths for creativity, personal growth, and transformation. In today's episode, we discuss: Honor your pivot points. Notice the moments whernt feels like a dead end. What would be different if you chose to see it as a time to redesign? Use every closed door or "mistake" as information for your next step. Allow creativity to be learned. Release the belief that you're "not creative" and give yourself permission to practice, experiment, and grow your skills one imperfect attempt at a time. Come home to your own truth. Gently question inherited beliefs, rules, and expectations so you can build a true relationship with yourself, the divine, and others that feels loving, spacious, and genuinely your. Choose communities that help you flourish. Intentionally seek out people who are curious, creative, and kind, knowing that "creativity breeds creativity" and you don't have to do it alone. Talk gently to your younger self. Revisit the bullied, lonely, or hurting version of you and let them know what's coming, so you can release old pain and stand more fully in who you are now. RESOURCES: Guest Bio: Melissa Muir is a metalsmith, educator, and trusted voice in the jewelry industry, known for bridging traditional craftsmanship with modern tools and techniques. With decades of hands-on experience at the bench, she specializes in jewelry fabrication, welding, stone setting, and emerging technologies such as pulse arc welding and engraving. As an educator and public speaker, Melissa is passionate about making complex processes approachable for both professional jewelers and dedicated hobbyists. Through workshops, online courses, product testing, and in-depth tool reviews, she empowers makers to work more confidently, efficiently, and creatively. Her clear, honest teaching style has made her a go-to resource for jewelers seeking practical knowledge they can immediately apply. Melissa is also the founder of Melissa Muir Metalsmith, where she shares education, demonstrations, and industry insights through video content, webinars, and live events. Her work focuses on raising the standard of jewelry education worldwide while inspiring makers to embrace innovation without losing sight of craftsmanship. Whether at the bench, on stage, or behind the camera, Melissa Muir is dedicated to helping jewelers refine their skills, invest wisely in tools, and rediscover joy in the making process. Website/Social Links: Melissa@melissamuir.com Www.instagram.com/metalsmithmelissa   Www.youtube.com/melissamuir Www.tictok.com/metalsmithmelissa Belinda's Bio:  Belinda is a sought-after Leadership Advisor, Coach, Consultant and Keynote speaker and a leading authority in guiding global executives, professionals and small business owners to become today's highly respected leaders. As the Founder of BelindaPruyne.com, Belinda works with such organizations as IBM, Booz Allen Hamilton, BBDO, The BAM Connection, Hilton, Leidos, Yale School of Medicine, Landis, and the Discovery Channel. Most recently, she redesigned two global internal advertising agencies for Cella, a leader in creative staffing and consulting. She is a founding C-suite and executive management coach for Chief, the fastest-growing executive women's network. Since 2020, Belinda has delivered more than 72 interviews with top-level executives and business leaders who share their inner journey to success; letting you know the truth of what it took to achieve their success in her Notable Leaders Radio podcast. She gained a wealth of expertise in the client services industry as Executive Vice President, Global Director of Creative Management at Grey Advertising, managing 500 people around the globe. With over 20+ years of leadership development experience, she brings industry-wide recognition to the executives and companies she works with. Whether a startup, turnaround, acquisition, or global corporation, executives and companies continue to turn to Pruyne for strategic and impactful solutions in a rapidly shifting economy and marketplace.   Website: Belindapruyne.com Email Address: hello@belindapruyne.com LinkedIn: https://www.linkedin.com/in/belindapruyne  Facebook: https://www.facebook.com/NotableLeadersNetwork.BelindaPruyne/  Twitter: https://twitter.com/belindapruyne?lang=en  Instagram: https://www.instagram.com/belindapruyne/ 

This winter has been incredibly cold in New York City. With long days spent inside and with the sun going down early, many might be struggling with Seasonal Affective Disorder, also known as seasonal depression. Dr. Paul Desan, associate professor of psychiatry at the Yale School of Medicine, gives listeners a better understanding of how Seasonal Affective Disorder works and tips for how to combat it.Stock graphic via iStock / Getty Images Plus

Today on Mea Culpa, I sit down with Jeffrey Sonnenfeld, senior associate dean at Yale School of Management, founder of the Chief Executive Leadership Institute, and author of the forthcoming book Trump's Ten Commandments, to examine Donald Trump's leadership style through the lens of corporate power and institutional behavior. An early critic dating back to The Apprentice, Sonnenfeld draws on decades of research on CEOs and crisis leadership, paired with my firsthand experience with Trump, to break down how he governs through intimidation, retaliation, and has an inability to accept loss. We explore why appeasement by universities, corporations, and civic institutions only accelerates democratic erosion, the risks of normalizing coercion, and whether collective resistance remains one of the most effective counterweights to abuse of power. Subscribe to Michael's Substack: https://therealmichaelcohen.substack.com/ Subscribe to Michael's YouTube Channel: https://www.youtube.com/@TheMichaelCohenShow Learn more about your ad choices. Visit megaphone.fm/adchoices

From Washington, D.C. to the Brooklyn waterfront, Lindsay Green shares how a career in finance evolved into a mission to transform industrial spaces into engines of opportunity for underserved communities.Lindsay Green is the President and CEO of the Brooklyn Navy Yard, where she leads one of New York City's most ambitious models for inclusive economic development. With more than 550 businesses and 11,000 employees on site, the Navy Yard is not simply a real estate portfolio but a living ecosystem designed to create quality jobs and connect local residents to meaningful careers. Her work blends business strategy, workforce development, and community engagement into a powerful example of how cities can rethink the purpose of former industrial spaces.Her journey began in Washington, D.C., where daily exposure to economic disparities shaped her desire to work at the intersection of business and community impact. After studying economics at Harvard and starting her career in investment banking at Goldman Sachs, she discovered urban development through the Urban Investment Group under Alicia Glen. Mentorship from leaders like Glen and MIT professor Phil Thompson helped her shift from traditional finance to mission driven economic development. A detour into the food industry after Yale School of Management eventually led her back to this work, culminating in her leadership at the Navy Yard in 2022.Lindsay explains how the Brooklyn Navy Yard goes beyond affordable real estate to support small, women owned, and minority owned businesses with mentorship, capital access, and technical advisory services. She highlights the Brooklyn STEAM Center, a public high school that gives 600 students hands on training with industry grade equipment, as well as new adult reskilling programs that recognize the value of both digital and analog problem solving. Through initiatives like the Micro Business Accelerator Program, she is building pathways for entrepreneurs to start small, grow, and scale within a supportive ecosystem.This conversation explores leadership, economic mobility, and the importance of early exposure to career possibilities. Lindsay's work demonstrates that revitalizing industrial spaces can do more than preserve history. It can create futures. Tune in to hear how thoughtful economic development can reshape communities and expand opportunity for the next generation.Chapters:00:00

Howie and Harlan are joined by geneticist and endocrinologist Joel Hirschhorn to discuss how thousands of genetic variants collectively shape disease and traits like height and obesity. Harlan reviews new research on diet soda and dementia; Howie surveys recent market swings, including the rise of Solace Health and the decline of Hims & Hers. Show notes: Diet Soda and Dementia "Soda consumption and risk of dementia: The Northern Manhattan study"  "Why One Cardiologist Has Drunk His Last Diet Soda" Joel Hirschhorn National Human Genome Research Institute: Mendelian Inheritance MedlinePlus: FGFR3 gene  Cleveland Clinic: Achondroplasia National Human Genome Research: Polygenic Trait  Hirschhorn Lab "A saturated map of common genetic variants associated with human height"  "What are single nucleotide polymorphisms (SNPs)?" ScienceDirect: Genetic Variant Joel Hirschhorn: "Genome-Wide Association Study of Quantitative Kidney Function in 52,531 Individuals with Diabetes Identifies Five Diabetes-Specific Loci" Joel Hirschhorn: "Polygenic prediction of body mass index and obesity through the life course and across ancestries" "Obesity Prediction Could Be Guided by Genetic Risk Scores" "Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of β-thalassemia"  Society for Science: Noam Elkies MIT: Eric S. Lander Ups and Downs "Understanding Creative Destruction: Driving Innovation and Economic Change" "Solace Health raises $130M series C for advocacy platform" "Molina Healthcare's stocks fall as company plans exit from Medicare Advantage"  "Centene swings to loss but predicts stabilization in 2026" "UnitedHealth limps into 2026 with a smaller business and fresh challenges" "Hims & Hers Falls 14% After Pulling Copycat Wegovy Pill—Novo Nordisk Up 8%"  "Compounding and the FDA: Questions and Answers" In the Yale School of Management's MBA for Executives program, you'll get a full MBA education in 22 months while applying new skills to your organization in real time. Yale's Executive Master of Public Health offers a rigorous public health education for working professionals, with the flexibility of evening online classes alongside three on-campus trainings. Email Howie and Harlan comments or questions.

For the first time on the WTTA podcast, we're joined by a researcher, and not just any researcher.Michael Sodini and Kevin Berry sit down with Kerri Raissian, Senior Research Scientist at the Yale School of Public Health's Firearm Injury Prevention Initiative. Kerri shares her path from growing up on a cattle farm in Texas, to working in a district attorney's office and running one of the largest domestic violence shelters in the country, to becoming a researcher focused on what actually reduces injury, trauma, and death.This conversation goes straight to the real tension points, without the usual talking past each other:The difference between reducing firearm deaths vs reducing overall deaths and why substitution mattersWhat gun owners worry about with ERPOs, and what it would take for policies to be trusted and usableWhy secure storage keeps showing up as a high-impact solution, including the reality of firearm theft from vehiclesHow research funding changed after 2020 and why more universities are building firearm research initiatives nowWhy storytelling and lived experience still matter even in data-driven policy workIt's candid, nuanced, and exactly what it looks like when the research community and firearm community sit at the same table and actually try to build answers together.Send a text Walk the Talk America would like to thank our partners who make these conversations possible and would like to highlight our top two partner tiers below! Platinum Tier:RugerArmscorBleeker Street PublicationsGold Tier:NASGWLipsey'sDavidson's

Today, on Notable Leaders' Radio, I speak with you as I launch the new "Still Becoming" series. I highlight how the journey of growth and self-discovery continues long after success is achieved, inviting you to explore the moments of untapped courage, unexpected opportunities, and personal evolution that unfold beyond traditional milestones. In today's episode, we discuss: Explore life beyond achievement. Reflect on the moment when hitting goals and earning recognition stopped answering everything, and consider whether it's time to redesign what success looks like for you now. Listen for your quiet evolution. Notice the subtle inner shifts, new perspectives, expanded freedom, unexpected gentleness with yourself, that change how you see your work, your impact, and what's truly possible. Let the unexpected become a doorway. Revisit the chapters you never planned, a random elevator conversation, a surprise opportunity, a path you "stumbled into", that you now wouldn't give back for anything. Tap your untapped courage. Acknowledge the deeper reservoir of bravery it takes to step away from predictability, trust your inner knowing, and say yes when your path is no longer obvious or linear. Choose meaning over momentum. Ask where you're sprinting on autopilot and where you're ready to consciously trade speed for impact, alignment, and the kind of contribution that actually matters to you. Define what "more" means for you now. Let go of one-size-fits-all ambitions and get curious about your current version of "more" in this season—more joy, more presence, more service, more creativity—and honor that as valid and enough. RESOURCES: Belinda's Bio: Belinda is a sought-after Leadership Advisor, Coach, Consultant and Keynote speaker and a leading authority in guiding global executives, professionals and small business owners to become today's highly respected leaders. As the Founder of BelindaPruyne.com, Belinda works with such organizations as IBM, Booz Allen Hamilton, BBDO, The BAM Connection, Hilton, Leidos, Yale School of Medicine, Landis, and the Discovery Channel. Most recently, she redesigned two global internal advertising agencies for Cella, a leader in creative staffing and consulting. She is a founding C-suite and executive management coach for Chief, the fastest-growing executive women's network. Since 2020, Belinda has delivered more than 72 interviews with top-level executives and business leaders who share their inner journey to success; letting you know the truth of what it took to achieve their success in her Notable Leaders Radio podcast. She gained a wealth of expertise in the client services industry as Executive Vice President, Global Director of Creative Management at Grey Advertising, managing 500 people around the globe. With over 20+ years of leadership development experience, she brings industry-wide recognition to the executives and companies she works with. Whether a startup, turnaround, acquisition, or global corporation, executives and companies continue to turn to Pruyne for strategic and impactful solutions in a rapidly shifting economy and marketplace. Website: Belindapruyne.com Email Address: hello@belindapruyne.com LinkedIn: https://www.linkedin.com/in/belindapruyne  Facebook: https://www.facebook.com/NotableLeadersNetwork.BelindaPruyne/  Twitter: https://twitter.com/belindapruyne?lang=en  Instagram: https://www.instagram.com/belindapruyne/ 

Synopsis: At the heart of JPM 2026's biotech buzz, Alok Tayi sits down with Fred Aslan, CEO of Artiva, to explore how bold platform bets, scalable cell therapies, and autoimmune breakthroughs could reshape medicine. Fred traces his journey from medical school in Brazil to consulting at BCG, venture capital, and ultimately founding multiple companies—sharing why following curiosity, not rigid career ladders, shaped his path. Fred dives deep into the bottlenecks holding back traditional CAR-T therapies—manufacturing complexity, cost, hospitalization, and toxicity—and explains how Artiva's off-the-shelf NK-cell platform aims to change the paradigm. The discussion explores why rheumatoid arthritis became Artiva's lead indication, how immune “resets” could redefine autoimmune care, and what's ahead in 2026 as the company prepares registrational trials and expands its basket studies across lupus, myositis, scleroderma, and more. The episode closes with rapid-fire takes on AI in drug development, China's accelerating biotech engine, rare disease trial models, and the strategic principles founders should follow when choosing indications and building durable platforms. Biography: Fred Aslan, M.D., has a 20-year track record as an executive and investor in the life sciences industry. He was most recently President and CBO at Vividion Therapeutics, where he was responsible for business development, finance, alliance and project management, and operations. Dr. Aslan had the opportunity to lead Vividion's Series B financing and $135M-upfront collaboration with Roche. Prior to Vividion, Dr. Aslan had a 12-year affiliation with Venrock. Initially he was an investor from 2006 to 2013, when he cofounded and served as a board member of Receptos Pharmaceuticals (acquired by Celgene for more than $7 billion). Dr. Aslan led Venrock's investment in Zeltiq (acquired by Allergan for more than $2 billion) and was involved in the early formation of Fate Therapeutics. Subsequently as an entrepreneur from 2013 to 2018, he was CEO of Adavium Medical, a Brazilian medical device company, which he grew from zero to 350 employees, sales of over US$40 million, and fully integrated R&D, manufacturing, and commercial capabilities. Prior to Venrock, Dr. Aslan was Director of Business Development and Head of Investor Relations for CuraGen, a Nasdaq-listed oncology-focused biotech company. Prior to CuraGen, he was a consultant at Boston Consulting Group (BCG). Dr. Aslan holds a B.S. in biology from Duke University, an M.D. from Yale School of Medicine, and an MBA from Harvard Business School.

Howie and Harlan discuss an escalating measles outbreak in the U.S. and a project piloted by Yale School of Medicine professor Erica Spatz to deliver preventative care in barbershops and beauty salons. Also examined: flu season, nipah virus, and the perils of focusing on healthcare business models. Show notes:  Measles CDC: Measles Outbreak Associated with an Infectious Traveler—Colorado, May–June 2025 CDC: Measles Cases and Outbreaks Snohomish County Health Department: Snohomish County Confirms Three New Measles Cases "Measles in an ICE facility is a public health failure" Value-Based Care "Value-Based Care: What It Is, and Why It's Needed" "Supporting Value-Based Health Care—Aligning Financial and Legal Accountability" American Hospital Association: 3 Ways AI Can Improve Revenue-Cycle Management Preventative Cardiology Yale School of Medicine: Erica Spatz, MD, MHS Pressure Check Marketplace Health Insurance Centers for Medicare & Medicaid Services: Marketplace 2026 Open Enrollment Period Report: National Snapshot Respiratory Illness CDC: Weekly US Influenza Surveillance Report: Key Updates for Week 3, ending January 24, 2026 "After 3-week decline, flu cases rise across the US; RSV, COVID activity high in certain states" Nipah Virus CDC: About Nipah Virus WHO: Nipah virus infection—India In the Yale School of Management's MBA for Executives program, you'll get a full MBA education in 22 months while applying new skills to your organization in real time. Yale's Executive Master of Public Health offers a rigorous public health education for working professionals, with the flexibility of evening online classes alongside three on-campus trainings. Email Howie and Harlan comments or questions.

Based in Brooklyn, NY (b. 1986, Taishan, China), Ye Zhu is an interdisciplinary artist focused on painting, public art, and social practice. He has presented solo exhibitions at DIMIN (2023) and Harkawik (2022) in New York, NY; at Moskowitz Bayse (2021) in Los Angeles, CA; and at the Andrew Freedman Home in the Bronx, NY (2022). His work has been included in group exhibitions at The Sugar Hill Museum in Harlem, NY (2022–23), Gavlak Gallery in Los Angeles (2023), Galerie Marguo in Paris, Harper's (2023, 2021), and James Fuentes (2021) in New York. Over the past year (2024–25), he completed residencies at the Lower Manhattan Cultural Council (LMCC), Dieu Donné Workspace in Brooklyn, and Wave Hill in the Bronx. Zhu has created numerous public projects, including a tribute installation for healthcare workers at the Yale School of Medicine (2022), a billboard project with Kingsgate Project Space in London (2021), A Universe in Strafford, NH (2021), and CONSTELLATION on Governors Island (2021), featured in The New York Times. He is a founding member of Haven Arts Park (2020–2023), an initiative dedicated to transforming contaminated land into an art park, and was a recipient of the Andrew W. Mellon Foundation grant (2022–2023). The Cosmos of Seeds, 144″ x 96″ Ego Decay, 96″ x 48″ Star Studded Snail, 42 x 39

Howie and Harlan are joined by internist and author Robert Wachter to discuss his new book, which explores how AI is already changing day-to-day medical practice and argues that it can improve care, reduce burnout, and even help repair a broken healthcare system. Show notes: Robert Wachter: A Giant Leap: How AI Is Transforming Healthcare and What That Means for Our Future Robert Wachter: The Digital Doctor: Hope, Hype, and Harm at the Dawn of Medicine's Computer Age Robert Wachter: "Pattern Recognition" "AI Prognosis: Readers' predictions for health AI in 2026. What's on your bingo card?" Robert Wachter: "Will The AI Jobpocalypse Hit Healthcare?" Video: Geoff Hinton on deep learning and radiology "Call me Dr Ishmael: trends in electronic health record notes available at emergency department visits and admissions" "OpenAI launches ChatGPT Health to connect user medical records, wellness apps" "Utah launches first-in-the-nation trial that lets AI renew your prescription" Robert Wachter: "Will AI Rescue Primary Care?" "We found what you're asking ChatGPT about health. A doctor scored its answers." Robert Wachter: "We Need Medical AI for Patients" Robert Wachter: "Medicine's AI Knowledge War Heats Up"  Josiah Macy Jr. Foundation Conference on Artificial Intelligence in Medical Education: Proceedings and Recommendations Robert Wachter: Deskilling and Healthcare AI" "Are A.I. Tools Making Doctors Worse at Their Jobs?" "The Robot Doctor Will See You Now" Atul Gawande: "Personal Best" In the Yale School of Management's MBA for Executives program, you'll get a full MBA education in 22 months while applying new skills to your organization in real time. Yale's Executive Master of Public Health offers a rigorous public health education for working professionals, with the flexibility of evening online classes alongside three on-campus trainings. Email Howie and Harlan comments or questions.

Howie and Harlan are joined by Mary-Ann Etiebet of the public health organization Vital Strategies to discuss how policy, prevention, and stronger public-health systems can reduce the global burden of cardiovascular disease, diabetes, and other preventable conditions. Harlan reports on the federal push toward fully autonomous clinical care for heart failure; Howie looks at proposed cuts to Medicare Advantage payments and what they mean for beneficiaries, plans, and taxpayers. Show notes: Autonomous Care SAM.gov: Agentic AI-EnableD CardioVascular CAre TransfOrmation (ADVOCATE) Proposers' Day Special Notice  "ARPA-H to revolutionize cardiovascular disease management with clinical agentic AI"  ARPA-H: Agentic AI-Enabled Cardiovascular Care Transformation  Mary-Ann Etiebet Health & Veritas Episode 7: Dr. Mary-Ann Etiebet: Saving Mothers' Lives  Vital Strategies  WHO: Noncommunicable diseases WHO: Global NCD Compact 2020–2030 "Health Taxes Are a Triple Win for African Countries—New Brief From Vital Strategies and Partners Provides Strategy" Mary-Ann Etiebet: "Using Health Taxes to Promote Public Good"  "'Historic Public Health Victory': Vital Strategies Applauds Brazil's Approval of Selective Tax on Tobacco, Soft Drinks, and Alcohol" Vital Strategies: Partners WHO: Civil registration and vital statistics  HHS: United States Completes WHO Withdrawal WHO statement on notification of withdrawal of the United States Medicare Advantage Centers for Medicare & Medicaid Services: "CMS Proposes 2027 Medicare Advantage and Part D Payment Policies to Improve Payment Accuracy and Sustainability" "Medicare Advantage in 2025: Enrollment Update and Key Trends" "Trump administration signals there's widespread desire to curb Medicare Advantage"  "Medicare Rates Shock Sparks $100 Billion Selloff in Insurers" In the Yale School of Management's MBA for Executives program, you'll get a full MBA education in 22 months while applying new skills to your organization in real time. Yale's Executive Master of Public Health offers a rigorous public health education for working professionals, with the flexibility of evening online classes alongside three on-campus trainings. Email Howie and Harlan comments or questions.

Last year, the National Institutes of Health drastically cut funding for medical research. This disrupted the work of academics and researchers across the country. Clinical trials and scientific projects were cancelled, and funding for ongoing research was revoked. This meant big cuts in funding to research institutions here in Connecticut. UConn lost $41 million from research grant terminations and unexpected non-renewals. Today, we hear how these cuts are impacting research institutions in our state and the future of science. GUESTS: Rob Stein: Correspondent and Senior Editor, on NPR’s Science Desk Evan Morris: Professor of Radiology and Biomedical Imaging and of Biomedical Engineering at Yale School of Medicine Diane Owens: mother of a pediatric patient with neurofibromatosis Support the show: http://wnpr.org/donateSee omnystudio.com/listener for privacy information.

At the beginning of December 2026: ICE announced an enforcement surge in the Twin Cities.January 6, 2026: DHS announced what it called the largest immigration enforcement operation ever carried out, sending 2,000 agents to the Minneapolis–Saint Paul metropolitan area. January 7, 2026: ICE agent Jonathan Ross fatally shoots Renée Nicole GoodJanuary 8–14, 2026: Protests, vigils, and marches continue in Minneapolis against ICE and Operation Metro SurgeJanuary 13, 2026: ‘Madness': two US citizens violently detained by ICE in Minnesota, officials say. Two Target employees forced to the ground, then into SUV, then dumped in different parking lotJanuary 14, 2026: A different ICE agent shoots and injures a man in north Minneapolis; the man survives after being shot in the leg. This second shooting further intensifies public anger and calls for an end to the federal surgeJanuary 17, 2026: National Anger Spills Into Target Stores, AgainJanuary 22, 2026: Target Store Staff Are Skipping Work Over ICE's Crackdown in MinnesotaJanuary 23, 2026: A statewide Day of Truth & Freedom / Minnesota general strike is held, described as the first U.S. general strike in about 80 years, explicitly targeting ICE operations and Operation Metro Surge. On that day, many workers, businesses, schools, and institutions in Minneapolis and across Minnesota participate in work stoppages, marches, and large rallies against federal immigration enforcement.January 24, 2026: Federal Border Patrol agents assigned to the metro surge shoot and kill Alex Jeffrey PrettiJanuary 25, 2026: The Minnesota Chamber of Commerce released this letter on behalf of more than 60 CEOs of Minnesota-based companies today.Eight people have died in dealings with ICE so far in 2026. Keith Porter, Parady La, Heber Sanchaz Domínguez, Victor Manuel Diaz, Luis Beltran Yanez-Cruz, Luis Gustavo Nunez Caceres, and Geraldo Lunas Campos. The high-profile fatal shootings follow the deaths of at least 32 people in ICE custody in 2025 – the highest number since 2004.Minnesota CEOs Seek De-Escalation After Border Police Shooting“The business community in Minnesota prides itself in providing leadership and solving problems to ensure a strong and vibrant state. The recent challenges facing our state have created widespread disruption and tragic loss of life. For the past several weeks, representatives of Minnesota's business community have been working every day behind the scenes with federal, state and local officials to advance real solutions. These efforts have included close communication with the Governor, the White House, the Vice President and local mayors. There are ways for us to come together to foster progress. With yesterday's tragic news, we are calling for an immediate deescalation of tensions and for state, local and federal officials to work together to find real solutions. We have been working for generations to build a strong and vibrant state here in Minnesota and will do so in the months and years ahead with equal and even greater commitment. In this difficult moment for our community, we call for peace and focused cooperation among local, state and federal leaders to achieve a swift and durable solution that enables families, businesses, our employees, and communities across Minnesota to resume our work to build a bright and prosperous future. “3M – William Brown, Chairman and CEOAmeriprise Financial – James Cracchiolo, Chairman and CEOAPi Group – Russell Becker, CEOBest Buy – Corie Barry, CEO C.H. Robinson – Dave Bozeman, President and CEODeluxe Corporation – Barry McCarthy, President and CEODonaldson Company, Inc. – Tod Carpenter, Chairman and CEOEcolab – Christophe Beck, Chairman and CEOGeneral Mills – Jeff Harmening, Chairman and CEOH.B. Fuller – On behalf of our entire organization [CEO Celeste Mastin]Hormel – Jeff Ettinger, Interim CEOMedtronic – Geoff Martha, CEO and ChairmannVent – Beth Wozniak, Chair and CEO Patterson Companies – Robert Rajalingam, CEOPentair – John L. Stauch, President and CEOPiper Sandler – Chad Abraham, Chairman and CEOSleep Number – Linda Findley, CEO (4/2025)Solventum – Bryan Hanson, CEOSPS Commerce – Chad Collins, CEO SunOpta – Brian Kocher, CEOTarget – Michael Fiddelke, Incoming CEO Tennant Company – Dave Huml, CEOThe Toro Company – Rick Olson, Chairman and CEOU.S. Bancorp – Gunjan Kedia, CEOWinnebago Industries – Michael Happe, CEOXcel Energy – Bob Frenzel, Chairman and CEO Keith Rabois, Managing director of Khosla Ventures: “no law enforcement has shot an innocent person. illegals are committing violent crimes everyday.”Khosla Ventures: “We prefer brutal honesty to hypocritical politeness.”“Technology and innovation have reshaped our world and disrupted the way we all live and work. The future may not be knowable, but it is inventable—and it belongs to those who dare to imagine what's possible.”Managing Directors: 5 dudes (3 stanford; 3 harvard)Founder Vinod Khosla: “I agree with @EthanChoi7. Macho ICE vigilantes running amuck empowered by a conscious-less administration. The video was sickening to watch and the storytelling without facts or with invented fictitious facts by authorities almost unimaginable in a civilized society. ICE personnel must have ice water running thru their veins to treat other human beings this way. There is politics but humanity should transcend that”Target's incoming CEO Michael Fiddelke in a video message sent to employees (January 26, 2026): “Right now, as someone who is raising a family here in the Twin Cities and as a leader of this hometown company I want to acknowledge where we are. The violence and loss of life in our community is incredibly painful. I know it's weighing heavily on many of you across the country, as it is with me. What's happening affects us not just as a company but as people, as neighbors, friends and family members.”A company spokesman declined to comment. Still nothing official on website.Lloyd Vogel, CEO Garage Grown Gear: said he felt compelled to condemn the shootings in a LinkedIn post because he lives and works in the Twin Cities. "My primary rationale was to show solidarity with my community," he told Business Insider. "It's also just bad for business when people are afraid to leave their homes.""There's so much fear in Minnesota right now," he said. "It would just be cowardice to not have a perspective on this."JPMorgan Chase CEO and Chair Jamie Dimon 1/22/26 Davos): ″I don't like what I'm seeing, five grown men beating up a little old lady. So I think we should calm down a little bit on the internal anger about immigration… We need these people. They work in our hospitals and hotels and restaurants and agriculture, and they're good people.… They should be treated that way.”On Saturday evening (1/24/2026), top technology executives gathered in Washington to attend a screening of “Melania,” a documentary produced by Amazon about the first lady, Melania Trump. Black-tie event: guests were handed monogrammed buckets of popcorn, framed screening tickets for their trophy shelves, and a limited-edition copy of Trump's 2024 book of the same title as her documentary, “Melania.“Among them was Andy Jassy, the chief executive of Amazon; Tim Cook, the chief executive of Apple; and Lisa Su, the chief executive of chip maker AMD.Also: Eric Yuan – CEO, Zoom; Lynn Martin – President, New York Stock Exchange; General Electric CEO Larry CulpApple CEO Tim Cook says it's 'time for de-escalation' in MinneapolisCook came under fire for appearing at The White House just hours after federal immigration authorities killed Alex Pretti, a veterans' nurse, in Minnesota“This is a time for de-escalation,” Cook wrote to Apple staff. “I believe America is strongest when we live up to our highest ideals, when we treat everyone with dignity and respect no matter who they are or where they're from, and when we embrace our shared humanity.”Cook said he “had a good conversation with the president this week where I shared my views, and I appreciate his openness to engaging on issues that matter to us all." Apple's Cook says he's ‘heartbroken' by Minneapolis events and has spoken with TrumpOpen AI CEO Sam Altman (1/27/26): I love the US and its values of democracy and freedom and will be supportive of the country however I can; OpenAI will too. But part of loving the country is the American duty to push back against overreach. What's happening with ICE is going too far. There is a big difference between deporting violent criminals and what's happening now, and we need to get the distinction right. President Trump is a very strong leader, and I hope he will rise to this moment and unite the country. I am encouraged by the last few hours of response and hope to see trust rebuilt with transparent investigations. As a company, we aim to stick to our convictions and not get blown around by changing fashions too much. We didn't become super woke when that was popular, we didn't start talking about masculine corporate energy when that was popular, and we are not going to make a lot of performative statements now about safety or politics or anything else. But we are going to continue to try to figure out how to actually do the right thing as best as we can, engage with leaders and push for our values, and speak up clearly about it as needed.James Dyett, Global Business at OpenAI: “There is far more outrage from tech leaders over a wealth tax than masked ICE agents terrorizing communities and executing civilians in the streets. Tells you what you need to know about the values of our industry.”Angel Investor Jason Calacanis: Once again, I will remind everyone that our leaders are failing us. True leadership would be to calm this situation down by telling these non-peaceful protestors to stay home while recalling these inadequately-trained agents.”Jeff Dean, Chief Scientist, Google DeepMind & Google Research. Gemini Lead: “This is absolutely shameful. Agents of a federal agency unnecessarily escalating, and then executing a defenseless citizen whose offense appears to be using his cell phone camera. Every person regardless of political affiliation should be denouncing this.”Jeffrey Sonnenfeld, senior associate dean for leadership studies at the Yale School of Management: "CEOs are feeling the community pressure." He said that reactions that convey sorrow and don't mention Trump or ICE are likely to be perceived as an unwelcome challenge to the White House's immigration agenda. "That is not what the Trump administration wanted," he said.Business Roundtable CEO Joshua Bolten asked to comment on the chaos in Minneapolis: replied with a statement endorsing the Minnesota Chamber's call for "cooperation between state, local, and federal authorities to immediately de-escalate the situation in Minneapolis."Robert Pasin, CEO of toy company Radio Flyer: recently shared an email on LinkedIn that he sent to his employees that was critical of the shootings in Minneapolis: "I am deeply concerned about the current state of our democracy, and the continued actions we are seeing from President Trump and his administration that are intended to undermine democratic institutions, the rule of law, and the norms that hold our country together."Dario Amodei, CEO Anthropic: called the events in Minnesota a “horror” on Monday. An Anthropic spokeswoman said the company did not have contracts with ICE.ICEout.tech statement from January 24, 2026: "We condemn the Border Patrol's killing of Alex Pretti and the violent surge of federal agents across our cities. The wanton brutality we've seen from ICE and CBP has removed any credibility that these actions are about immigration enforcement. Their goal is terror, cruelty, and suppression of dissent. This must end. Tech professionals are speaking up against this brutality, and we call on all our colleagues who share our values to use their voice. We know our industry leaders have leverage: in October, they persuaded Trump to call off a planned ICE surge in San Francisco, and big tech CEOs are in the White House tonight. Now they need to go further, and join us in demanding ICE out of all of our cities." 811: 508 names; 19 one name with title, 284 role onlyReid Hoffman says business leaders are wrong to stay silent about the Trump administrationThe LinkedIn cofounder and tech investor said in an episode of the "Rapid Response" podcast published Tuesday that he rejects the idea that executives can simply wait out political turbulence: "The theory that if you just keep your mouth shut, the storm will blow over and it won't be a problem — you should be disabused of that theory now," Hoffman said.Palantir Defends Work With ICE to Staff Following Killing of Alex Pretti: Leadership defended its work as in part improving “ICE's operational effectiveness.”

Much of the popular personal financial advice that reaches the average person doesn't come from economists or professors. It often comes from writers and radio hosts that in some cases have amassed millions of followers and risen to prominence through widely available, low-cost financial guidance. On the next episode of The Behavioral Divide, Professor Hal Hershfield discusses this reality with James Choi, Professor of Finance at the Yale School of Management. Professor Choi has done extensive research examining the 50 most popular personal finance books to identify where their central themes match, and where they fail to align, with the academic literature. They discuss this work, as well as the most significant findings from academia that Professor Choi believes have failed to make it into the common practices of financial advisors and could potentially make a big difference for your clients. If you enjoy the show, please subscribe or let us know by giving our series a five-star rating. We'd also love to hear from you. To join in on the discussion, send us a note at BehavioralDivide@AvantisInvestors.com. Important Disclosures The views expressed in this presentation are the speaker's own and not necessarily those of American Century Investments. This presentation is for general information only and is not intended to provide investment, tax or legal advice or recommendations for any particular situation or type of retirement plan. Please consult with a financial, tax or legal advisor on your own particular circumstances. Hal Hershfield is not affiliated with American Century Investments. Follow us on social media: LinkedIn: https://a.vant.is/4ppUSVI X: https://a.vant.is/4psIwMw Subscribe to The Behavioral Divide podcast: Spotify: https://a.vant.is/3IlDEIy Apple: https://a.vant.is/3IgEhDe

Bess Wohl joins the podcast to discuss the journey of bringing her latest play, Liberation, to Broadway after a decade of development. She shares the "woo woo" details of her creative process, describing a vision of her characters waiting in a metaphorical doctor's office for her to finally tell their stories. Bess reflects on how the play, which travels between the 1970s Women's Liberation Movement and the present day, became unexpectedly urgent in the current political climate. The conversation dives into Bess's transition from an acting student at Yale Drama to an acclaimed playwright, a shift she describes as almost destined. She explains her rebellious approach to writing, from the "masterclass in silence" found in Small Mouth Sounds to the vulnerable, full-ensemble nudity in Liberation. Through stories of her mother's time at Ms. Magazine and her own experiences in the rehearsal room, Bess highlights how storytelling serves as a visceral exercise in empathy for audiences and actors alike. Bess Wohl is a Drama Desk and Outer Critics Circle Award winning playwright and filmmaker. Her body of work includes the Tony Award nominated Grand Horizons, as well as Small Mouth Sounds, Make Believe, American Hero, Continuity, Camp Siegfried, and the feature film Baby Ruby. A graduate of Harvard University and the Yale School of Drama, her plays have been produced on Broadway and at major theaters including Ars Nova and Second Stage. Connect with Bess: Instagram: @besswohl Connect with The Theatre Podcast: Support the podcast on Patreon and watch video versions of the episodes: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Patreon.com/TheTheatrePodcast⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@theatre_podcast⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook.com/OfficialTheatrePodcast⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TheTheatrePodcast.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Alan's personal Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@alanseales⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Email me at feedback@thetheatrepodcast.com. I want to know what you think. Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of TheHemOnc Pulse, Rahul Banerjee, MD, speaks with Francine Foss, MD, professor of medicine and dermatology at Yale School of Medicine, about the evolving landscape of T-cell lymphomas. Dr Foss discusses the unique challenges of studying and treating rare diseases such as cutaneous T-cell lymphoma and explains why real-world data are essential to closing evidence gaps. The conversation highlights the role of collaborative registries in tracking treatment patterns, outcomes, and access to care across community and academic settings. Dr Foss also shares how both clinicians and patients can participate in these efforts to strengthen research, inform future clinical trials, and improve outcomes for patients with T-cell lymphomas.

The 2026 U.S. Dietary Guidelines introduced an up-side down food pyramid that prioritizes meat, fats, and full-fat dairy. How healthy is this new food framework? We're joined by Dr. Nate Wood, head of culinary medicine at the Yale School of Medicine and a former chef to talk about avoiding processed foods and eating healthy.

Has Modern Technology Killed Evolution?  Modern advancements allow us to live in extreme environments and survive conditions that would've once  been fatal. Do these technological leaps mean our species has finally bypassed the ancient laws of biological evolution? Our expert explains how our unique development might actually be working in harmony with these environmental pressures rather than against them.Guest: Steve Reilly, PhD, assistant professor of genetics, Yale School of Medicine The Schizophrenia Spectrum: Early Warning Signs And Vague Symptoms  While Hollywood often portrays schizophrenia in its most extreme form, the actual progression of the disorder is much different than what we see on screen. This week, our expert explains why these symptoms are frequently misdiagnosed, how they can affect anyone under the right neurological conditions, and why identifying early warning signs is the most effective way to change the long-term outlook for patients.Guest: Dr. Christopher Correll, professor of psychiatry, Zucker School of Medicine, chief medical officer, MedLin Medical Notes: How Cancer Hijacks Our Internal Clock, The Dangers Of Dirt, And Is Alcohol Ever Good For You?  How cancer hijacks our internal clock. Why we should be wary of dirt. Science may have found a cure for nightmares. Is alcohol ever good for you? Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Has Modern Technology Killed Evolution?  Modern advancements allow us to live in extreme environments and survive conditions that would've once  been fatal. Do these technological leaps mean our species has finally bypassed the ancient laws of biological evolution? Our expert explains how our unique development might actually be working in harmony with these environmental pressures rather than against them.Guests: Steve Reilly, PhD, assistant professor of genetics, Yale School of MedicineHost: Elizabeth WestfieldProducer: Kristen Farrah Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In his weekly clinical update, Dr. Griffin and Vincent Racaniello discuss screwworm, how the shingles vaccination slows biological aging (for all of you who want to reset 'the clock' and live forever…..you know who you are Musk, Bezos) and getting one dose of the HPV vaccine, then Dr. Griffin then deep dives into recent statistics on RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, how losing our elimination status is the cost of doing business (going for broke is never a good business model !) where to find PEMGARDA, how to access and pay for Paxlovid, long COVID treatment center, the effectiveness of this season's influenza vaccine, where to go for answers to your long COVID questions and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode New World Screwworm: Outbreak Moves into Northern Mexico……with an official tag "This is an official CDC Health Advisory" (CDC: Health Alert Network) Association between shingles vaccination andslower biological aging: Evidence from a U.S. population-based cohort study (The Journals of Gerontology series A) Noninferiority of One HPV Vaccine Dose to Two Doses (NEJM) Herd effect of human papillomavirus vaccination on incidence of high-grade cervical lesions: (LANCET: Public Health) Confirmations of Highly Pathogenic Avian Influenza in Commercial and Backyard Flocks (USDA: Animal and Plant Health Inspection Service) Detections of Highly Pathogenic Avian Influenza in Wild Birds (USDA: Animal and Plant Health Inspection Service) Delaware, Georgia see major commercial avian flu outbreaks (CIDRAP) Wastewater for measles (WasterWater Scan) Notes from the Field: Wastewater Surveillance for Measles Virus During a Measles Outbreak — Colorado, August 2025 (CDC: MMWR) Notes from the Field: Retrospective Analysis of Wild-Type Measles Virus in Wastewater During a Measles Outbreak — Oregon, March 24–September 22, 2024 (CDC: MMWR) Measles cases and outbreaks (CDC Rubeola) Measles vaccine recommendations from NYP (jpg) Tracking Measles Cases in the U.S. (Johns Hopkins) Utah measles total rises to 216; CDC deputy director says losing elimination status'cost of doing business' (CIDRAP) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts (ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Assessing MMR vaccination coverage gaps in US children with digital participatory surveillance (Nature Health) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Weekly surveillance report: clift notes (CDC FluView) Effectiveness of influenza vaccination to prevent severe disease: a systematic review and meta-analysis of test-negative design studies (CMI: Clinical Microbiology and Infection) Interim vaccine effectiveness against influenza virus among outpatients, France, October 2025 to January 2026 (Eurosurveillance) Moderate protection from vaccination against influenza A(H3N2) subclade K in Beijing, China, September to December 2025 (Eurosurviellance) Current flu vaccine provides moderate protection against severe disease, interim analyses suggest (CIDRAP) OPTION 2: XOFLUZA $50 Cash Pay Option (xofluza) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) USrespiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virusnfection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Where to get pemgarda (Pemgarda) EUAfor the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) UnderstandingCoverageOptions (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulationguidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Reaching out to US house representative Letters read on TWiV 1290 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.In this Mind Moments episode, Benjamin Tolchin, MD, MS, FAAN, joins the podcast to provide clinical perspective on the recently published American Academy of Neurology (AAN) guidelines on functional seizures, drawing on his role as a contributing author to the recommendations. Tolchin, Director of the Center for Clinical Ethics at Yale New Haven Health and Associate Professor of Neurology at Yale School of Medicine, discusses what prompted the development of the first AAN guideline in this space and how the evidence base evolved to support formal recommendations. The conversation explores key considerations around diagnosing functional seizures, including history, semiology, EEG use, and the growing role of video documentation. Tolchin also addresses how clinicians should approach psychiatric comorbidities and co-occurring epilepsy, the evidence supporting psychological interventions, why pharmacologic therapies are not recommended for functional seizures themselves, and where major gaps remain in research to advance care in the years ahead.Looking for more Epilepsy discussion? Check out the NeurologyLive® Epilepsy clinical focus page.Episode Breakdown: 1:10 – Why growing evidence prompted the first AAN guideline on functional seizures 3:20 – Diagnostic priorities including history, semiology, EEG, and video documentation 6:15 – Assessing psychiatric comorbidities and co-occurring epilepsy in functional seizures 9:15 – Neurology News Minute 11:30 – Evidence supporting psychotherapy for functional seizures 14:50 – Pharmacological evidence and use of antiseizure medications for functional seizures 18:35 – Barriers to advancing clinical trials in functional seizures 22:05 – Research priorities to refine treatment and long-term outcomes The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here: FDA Approves Subcutaneous Copper Histidinate as First Treatment for Pediatric Menkes Disease sBLA Acceptance Positions Efgartigimod as Potential First Therapy for Seronegative Myasthenia Gravis High-Dose Nusinersen Gains European Commission Approval for Spinal Muscular Atrophy Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

Howie and Harlan are joined by health policy writer Jonathan Cohn to discuss the RFK Jr. food agenda, the barriers to universal healthcare in the U.S., and working alongside former political adversaries at The Bulwark. Harlan reports on a lawsuit exposing gaps in the privacy of medical-records systems; Howie highlights new research suggesting that a sharp drop in opioid overdose deaths may be temporary. Show notes: Data Privacy "Epic's lawsuit against Health Gorilla raises broader issues about the future of data sharing, industry executives say" The Trusted Exchange Framework and Common Agreement Jonathan Cohn The Bulwark The Bulwark: The Breakdown Jonathan Cohn: "The Real Story Behind the Minnesota Welfare Fraud Scandal" Jonathan Cohn: "How Somalis Became the New 'Welfare Queens'" FDA: Direct-to-Consumer (DTC) Advertisements FDA: Unique Device Identifiers Jonathan Cohn: "Trump's Assault on Health Care, Seen from a Country That Does Health Care Better" Jonathan Cohn: Sick: The Untold Story of America's Health Care Crisis—and the People Who Pay the Price Jonathan Cohn: "Michelle Obama Will Be Accepting Your Apologies Now"  "RFK Jr.'s new dietary guidelines go all in on meat and dairy"  Opioid Deaths CDC: Provisional Drug Overdose Death Counts  "Did the illicit fentanyl trade experience a supply shock?" In the Yale School of Management's MBA for Executives program, you'll get a full MBA education in 22 months while applying new skills to your organization in real time. Yale's Executive Master of Public Health offers a rigorous public health education for working professionals, with the flexibility of evening online classes alongside three on-campus trainings. Email Howie and Harlan comments or questions. 

What does it mean to feel safe during sex these days?From feeling comfortable with your partner to access to public health and medication, "safety" comes up a lot in sex. But, having the tools you need to feel confident in your own sexual health is an essential part of the pursuit of pleasure. Today, Brittany is joined by Dr. Leisha McKinley-Beach, founder and CEO of the Black Public Health Academy, and Dr. Jasmine Abrams, a research scientist at the Yale School of Public Health, to give us a New Year's booster on how to live our best sex lives — and explore how to feel safer in bed. Support Public Media. Join NPR Plus.Follow Brittany Luse on Instagram: @bmluseFor handpicked podcast recommendations every week, subscribe to NPR's Pod Club newsletter at npr.org/podclub.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Today, on Notable Leaders' Radio, I dive into exploring a simple but often overlooked question: Have you set yourself up for success, or expecting yourself to "just make it happen"? This conversation isn't about fixing what you've done in the past or pushing harder in the year ahead. It's about approaching your goals with greater clarity, compassion, and intention—so what matters most has a real chance to take root. In this episode, I reflect on: What it truly means to set yourself up for success Not through pressure or perfection, but through thoughtful preparation that builds confidence and capacity over time. How to reverse-engineer what you want to experience, create, or achieve Looking at daily, weekly, monthly, and quarterly rhythms that support growth in a way that's sustainable and realistic. Why warming up matters, on and off the field Using a pole-vaulting metaphor to explore how gradual expansion and attention to form prepare you for new levels of leadership and impact. The value of pausing to distinguish desire from obligation Gently asking whether a goal truly reflects what you want now—or whether it's something you've been carrying out of habit or expectation. At its heart, this episode is an invitation to replace self-demand with self-leadership, and to remember that professional success and personal fulfillment are not competing goals. They are meant to grow together. If you're looking to begin 2026 with greater clarity, alignment, and momentum, so better prepare yourself for celebrations at the end of the year, rather than disappointment with a list of things you did not accomplish. This podcast episode is for you. Belinda's Bio: Belinda is a sought-after Leadership Advisor, Coach, Consultant and Keynote speaker and a leading authority in guiding global executives, professionals and small business owners to become today's highly respected leaders. As the Founder of BelindaPruyne.com, Belinda works with such organizations as IBM, Booz Allen Hamilton, BBDO, The BAM Connection, Hilton, Leidos, Yale School of Medicine, Landis, and the Discovery Channel. Most recently, she redesigned two global internal advertising agencies for Cella, a leader in creative staffing and consulting. She is a founding C-suite and executive management coach for Chief, the fastest-growing executive women's network. Since 2020, Belinda has delivered more than 72 interviews with top-level executives and business leaders who share their inner journey to success; letting you know the truth of what it took to achieve their success in her Notable Leaders Radio podcast. She gained a wealth of expertise in the client services industry as Executive Vice President, Global Director of Creative Management at Grey Advertising, managing 500 people around the globe. With over 20+ years of leadership development experience, she brings industry-wide recognition to the executives and companies she works with. Whether a startup, turnaround, acquisition, or global corporation, executives and companies continue to turn to Pruyne for strategic and impactful solutions in a rapidly shifting economy and marketplace. Website: Belindapruyne.com Email Address: hello@belindapruyne.com LinkedIn: https://www.linkedin.com/in/belindapruyne  Facebook: https://www.facebook.com/NotableLeadersNetwork.BelindaPruyne/  Twitter: https://twitter.com/belindapruyne?lang=en  Instagram: https://www.instagram.com/belindapruyne/ 

Born in Tustin, California, James Nestor spent his teens surfing and playing in a straight-edge punk band called Care Unit. After graduating high school, he moved to the Bay Area, where he studied art and literature and earned an MFA.  Nestor's professional life began as a copywriter. Soon he moved into magazine journalism. His essays and features have appeared in Outside, Scientific American, The New York Times, The Atlantic, Dwell, The Surfer's Journal, and many others. His 2014 book, DEEP: Freediving, Renegade Science, and What the Ocean Tells Us About Ourselves, follows clans of extreme athletes, adventurers, and scientists as they plumb the ocean's depths and uncover surprising new discoveries. But his big book is, of course, 2020's Breath: The New Science of a Lost Art, which explores the million-year-long history of how we humans have lost the ability to breathe properly, and why we're suffering from various maladies because of it. Along with drawing on thousands of years of medical texts and recent cutting-edge studies in pulmonology, psychology, biochemistry, and human physiology, Nestor also found answers in the muddy digs of ancient burial sites, secret Soviet facilities, New Jersey choir schools, and the smoggy streets of Sao Paulo. In sum, Breath turns the conventional wisdom of what we thought we knew about our most basic biological function on its head. Nestor has been a guest speaker at Stanford Medical School, Harvard Medical School, Yale School of Medicine, and the United Nations. He currently lives in Portugal.  In this episode of Soundings, Nestor talks with Jamie Brisick about the fundamentals of breathwork, Ocean Beach, growing up in Orange County, his early days as a reporter, the values of freediving, and writing books. Produced by Jonathan Shifflett. Music by PazKa (Aska Matsumiya & Paz Lenchantin).

Irene Sofia Lucio stops by to discuss the journey from being a shy kid in Puerto Rico who had to force herself to raise her hand to starring in some of the most provocative plays on Broadway. She opens up about the intersection of motherhood and art, explaining how becoming a parent shifted her relationship with her body and why creative teams led by mothers are simply more efficient. We also dig into the "white passing" label she carried for years and how she finally decided to fully reclaim her Latinx identity and name in an industry that loves to categorize. We get into the specifics of her current role in Liberation, including the decision to wear a custom golden armor bust of her own body for opening night and the unique power of performing a nude scene while her father is in the audience. Irene shares how the play explores the history of women's liberation and why physical vulnerability on stage creates a "force field" of safety with her castmates. It is a candid look at how the political climate impacts performance and why gathering in a theater is a form of community building we desperately need right now. Irene Sofia Lucio is an actor and creator whose Broadway credits include Liberation, Slave Play, and Wit. Her Off-Broadway work includes Our Dear Dead Drug Lord. On screen, she has appeared in In the Heights, Tell Me Lies, The Big Cigar, and co-created the web series Butts. She holds a BA from Princeton University and an MFA from the Yale School of Drama. This episode is powered by WelcomeToTimesSquare.com, the billboard where you can be a star for a day. Connect with Irene: Instagram: @irenesofialucio Connect with The Theatre Podcast: Support the podcast on Patreon and watch video versions of the episodes: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Patreon.com/TheTheatrePodcast⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@theatre_podcast⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook.com/OfficialTheatrePodcast⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TheTheatrePodcast.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Alan's personal Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@alanseales⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Email me at feedback@thetheatrepodcast.com. I want to know what you think. Learn more about your ad choices. Visit megaphone.fm/adchoices

Lisa Morris is a board-certified Women's Health Nurse Practitioner. She's a graduate of Yale School of Nursing with five years of experience as a nurse practitioner. After gaining valuable experience in clinic-based settings, she started her own practice through The Mama Coach. Lisa is passionate about coaching women to achieve their health goals through a holistic approach—focusing on diet, stress management, lifestyle factors, and, when needed, prescription medications. She helps women navigate two of life's most challenging transitions: infertility and perimenopause. Whether it's supporting women who are trying to conceive or helping them find balance and confidence through hormonal changes, Lisa is committed to empowering every woman with knowledge and individualized care so she can feel understood, supported, and in control of her health.Sponsors:Bombas offers a wide variety of sock lengths, colors, and patterns that have you covered whether you're working out, going out, or lounging at home. If you want to upgrade your sock game to one that's more comfortable, durable, fashionable, and charitable, head over to ⁠Bombas⁠ to browse their full collection of everyday wear and don't forget to use code CDSF20 for 20% off your first order.ANCORE: Named the best portable cable machine by Men's Health Home Gym Awards. Head over to ⁠ancoretraining.com/cdsf10⁠ and use promo code CDSF10 for $50 off your order today.By combining the most potent organic nootropics found in nature, Drink Alchemy delivers sustainable boosts to creativity, memory, energy, & focus in one epic beverage. Enjoy the benefits of real ingredients, natural nootropics, and live with your Mind Unbound by going to ⁠drinkalchemy.co⁠ and use code CDSF at checkout for 10% off your order today.Thorne vitamins and supplements are made without compromise: quality ingredients ensure your body optimally absorbs and digests your daily supplements, while in-house and third-party testing ensure you're getting exactly what you paid for. Thorne's selection of high-quality supplements can help improve your quality of life. Switch to Thorne's high-quality and extensively tested supplements today at ⁠thorne.com/u/CDSF⁠.Marc Pro. Marc Pro is an electric muscle stimulator that focuses on improving recovery through its patented technology. Unlike a traditional TENS unit, the Marc Pro doesn't just mask your pain, it improves circulation, flushes lymphatic waste, reduces soreness and fatigue, and prevents overuse injuries – leading to improved performance in the gym and on the field. Start taking your recovery to the next level. Head over to Marc Pro and use code CDSF for 10% off your Marc Pro, Marc Pro Plus, or Boost Pro Massage gun.Intro/outro music: ⁠freebeats.io/⁠ (prod. White Hot)

As we turn the page on a new year, the neuroendocrine cancer community isn't just reflecting on progress—we're looking ahead. This episode of NETWise explores where the field is going next, and what that future means for patients, caregivers, and clinicians alike.Recorded in connection with the 2025 NETRF Neuroendocrine Cancer Research Symposium, this conversation brings together researchers, physicians, patient advocates, and NETRF leaders to examine the momentum shaping the years ahead.In this episode, you'll hear about:How emerging therapies—from PRRT advances to immune-based and cell therapies—are changing careWhy precision medicine, surface targeting, and biomarkers are defining the next era of researchNETRF's research roadmap, focused on early detection, improved treatments, and precision medicine.The growing role of patient education, self-advocacy, and “thrivership” in living well with NETs and Neuroendocrine CarcinomaHow collaboration across institutions and disciplines is accelerating progress toward better outcomesThis isn't just a vision of the future—it's the work already underway, and the direction the field is moving next.Whether you're a patient, caregiver, clinician, or advocate, this episode offers clear, accessible insights into the breakthroughs that’s driving the research forward.Please like, share, and subscribe. Your engagement helps us reach more patients and caregivers seeking reliable neuroendocrine cancer information—and supports NETRF's mission to expand research, awareness, and hope across the NET community. NET specialists included in this episodeUse our episode infographics to get a visual picture of some of the things we have discussed. Po-Hien Ear, PhDAssistant Professor of Surgery (Surgical Oncology & Endocrine Surgery), University of Iowa Carver College of Medicine Martyn Caplin, MD, PhD, FRCPProfessor of Gastroenterology & Tumour Neuroendocrinology, Royal Free Hospital & University College London (UCL) Carl Gay, MD, PhDAssistant Professor, Department of Thoracic/Head & Neck Medical OncologyDivision of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX Pamela L. Kunz, MDDirector, Center for Gastrointestinal Cancers, Smilow Cancer Hospital & Yale Cancer CenterChief, GI Medical Oncology, Yale School of Medicine Neil Renwick, MD, PhD, FRCPCAssistant Professor, Department of Pathology & Molecular Medicine, Queen's University(SEAMO New Clinician-Scientist Program) Nancy Joseph, MD, PhDProfessor of Surgical Pathology, University of California, San Francisco (UCSF) Iacovos Michael, PhDSunnybrook Research institute and University of Toronto Elsa Hadj Bachir, PhDResearch Fellow in Medicine Dana-Farber Cancer Institute Thank you to NETRF staff members Elyse Gellerman and Anna Greene, PhD, and NETRF Board Members Josh Mailman, and Todd Gillman for their contributions to this episode.A special thank you to Jake Dawson and Nancy Lewis for sharing their neuroendocrine cancer journeys. Download a transcript of this episode. The post Episode 51: A New Year— Where We're Going appeared first on NETRF.

Howie and Harlan are joined by health law and policy expert Sara Rosenbaum to discuss how incremental reform expanded healthcare access—and the urgent work now underway to prevent those gains from being undone. Harlan explores how AI is quietly filling gaps in the healthcare system; Howie highlights a milestone in the prevention of mother-to-child HIV transmission. Show notes: AI as a Healthcare Tool OpenAI: "AI as a Healthcare Ally" "Cost Leads Americans' Top-of-Mind Healthcare Concerns" "Physician sentiments around the use of AI in health care: motivations, opportunities, risks, and use cases" OpenAI: Introducing ChatGPT Health Sara Rosenbaum "The Policy Entrepreneur" KFF: Children's Health Insurance Timeline Sara Rosenbaum: "A 'Shift in Kind': A Medicaid Work Requirement Would Radically Change Health Policy" Sara Rosenbaum: "Implementing Medicaid Work Reporting Requirements: Defining A 'Serious Or Complex Medical Condition'" Sara Rosenbaum: "Who's Affected by Medicaid Work Requirements? It's Not Who You Think" "South Carolina reports 124 new measles cases as outbreak grows""Medical Groups Will Try to Block Childhood Vaccine Recommendations" CDC: About the Vaccines for Children (VFC) Program Sara Rosenbaum: "A Twenty-First Century Vaccines For Children Program" Sara Rosenbaum: "Nearly 5.6 Million Community Health Center Patients Could Lose Medicaid Coverage Under New Work Requirements, with Revenue Losses Up to $32 Billion" Sara Rosenbaum: "How Medicaid Built Community Health Centers and Health Centers Returned The Favor" KFF: 5 Key Facts About Medicaid and Provider Taxes "How New Limits on State Provider Taxes Will Affect Medicaid Funding" Preventing Mother-to-Child Infection "WHO validates Brazil for eliminating mother-to-child transmission of HIV" Health & Veritas Episode 178: Sarah DeSilvey: Creating Space for Healing "Why Syphilis Cases in Newborns Are Rising Even as STIs Decline" In the Yale School of Management's MBA for Executives program, you'll get a full MBA education in 22 months while applying new skills to your organization in real time. Yale's Executive Master of Public Health offers a rigorous public health education for working professionals, with the flexibility of evening online classes alongside three on-campus trainings. Email Howie and Harlan comments or questions.

One Yale economist certainly thinks so. But even if he's right, are economists any better? We find out, in this update of a 2022 episode. SOURCES:James Choi, professor of finance at the Yale School of Management.Morgan Housel, personal finance author and partner at the Collaborative Fund. RESOURCES:The Art of Spending Money: Simple Choices for a Richer Life, by Morgan Housel (2025).“Popular Personal Financial Advice versus the Professors,” by James J. Choi (Journal of Economic Perspectives, 2022).“Media Persuasion and Consumption: Evidence from the Dave Ramsey Show,” by Felix Chopra (SSRN, 2021).The Psychology of Money: Timeless Lessons on Wealth, Greed, and Happiness, by Morgan Housel (2020).“In Bogle Family, It's Either Passive or Aggressive,” by Liam Pleven (Wall Street Journal, 2013). EXTRAS: “Harold Pollack on Why Managing Your Money Is as Easy as Taking Out the Garbage,” by People I (Mostly) Admire (2021).“People Aren't Dumb. The World Is Hard,” by Freakonomics Radio (2018).“Everything You Always Wanted to Know About Money (But Were Afraid to Ask),” by Freakonomics Radio (2017).“The Stupidest Thing You Can Do With Your Money,” by Freakonomics Radio (2017). Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.